噜啦啦
Lv5
965 积分
2022-04-18 加入
-
Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial
11天前
已完结
-
Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial
11天前
已完结
-
Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial
11天前
已完结
-
A randomized controlled study of a combination of internal and external treatments for albumin paclitaxel-related peripheral neurotoxicity: A randomized controlled: A study protocol
12天前
已完结
-
Approach to High-Risk Multiple Myeloma
1个月前
已完结
-
Role of Pregabalin in Treatment of Polyneuropathy in Multiple Myeloma Patients: A Retrospective Study
1个月前
已完结
-
Current Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma
1个月前
已完结
-
Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma
1个月前
已完结
-
Multiple myeloma: Role of autologous transplantation
1个月前
已完结
-
Autologous Stem Cell Transplantation in Multiple Myeloma: Where Are We and Where Do We Want to Go?
1个月前
已完结